Cyclix
Active substance
ATC code
Species
Cows
Indications
Induction of luteolysis allowing resumption of oestrus and ovulation in cyclic females when used during dioestrus, synchronisation of oestrus (within 2 to 5 days) in groups of cyclic females treated simultaneously, treatment of suboestrus and uterine disorders related to a functioning or persistent corpus luteum (endometritis, pyometra), treatment of ovarian luteal cysts, induction of abortion until day 150 of pregnancy, expulsion of mummified foetuses, induction of parturition.
Dose to be administered and administration route
For all indications, 2 ml corresponding to 0,5 mg cloprostenol/animal, injected intramuscularly.
In order to synchronise oestrus in groups of females, it is recommended that the product is administered on two occasions with a between treatment interval of 11 days.
Adverse reactions
Anaerobic infection may occur if anaerobic bacteria penetrate the tissue at injection site, in particular following intramuscular injection.
When used for induction of parturition and dependent on the time of treatment relative to the date of conception, the incidence of retained placenta may be increased.
In very rare cases, anaphylactic-type reactions can be observed which might be lifethreatening and require rapid medical care.
The frequency of adverse reactions is defined using the following convention:
- very common (more than 1 in 10 animals treated, displaying adverse reaction(s))
- common (more than 1 but less than 10 animals in 100 animals treated)
- uncommon (more than 1 but less than 10 animals in 1,000 animals treated )
- rare (more than 1 but less than 10 animals in 10,000 animals treated)
- very rare (less than 1 animal in 10,000 animals treated, including isolated reports).
